Ann: Program Update Anagrelide, page-6

It is a solid announcement (with no mistakes!) and whilst I have certainly been critical of a lack of guidance and timelines I have to agree with Clyde on this particular product. clearly there is a lot to be done and Carter has been hung for giving and missing guidance. Probably safer to talk more generally about timeframes on this.

having said that I agree Name we still need a thorough update on everything else with reasons for things missed and what the new timeline is. force the market to believe in you Stephen. Us shareholders have no choice but the market needs to be convinced.